Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and July 2018

Showing 1 to 10 of 389
Title Reference number Published Last updated
Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer Reference number:TA531 TA00531 Published:July 2018 20180701 Last updated:July 2018 20180718
Cenegermin for treating neurotrophic keratitis Reference number:TA532 TA00532 Published:July 2018 20180701 Last updated:July 2018 20180718
Atezolizumab for untreated PD-L1-positive locally advanced or metastatic urothelial cancer when cisplatin is unsuitable Reference number:TA492 TA00492 Published:December 2017 20171201 Last updated:July 2018 20180712
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer Reference number:TA528 TA00528 Published:July 2018 20180701 Last updated:July 2018 20180704
Crizotinib for treating ROS1-positive advanced non-small-cell lung cancer Reference number:TA529 TA00529 Published:July 2018 20180701 Last updated:July 2018 20180704
Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapy Reference number:TA530 TA00530 Published:July 2018 20180701 Last updated:July 2018 20180704
Beta interferons and glatiramer acetate for treating multiple sclerosis Reference number:TA527 TA00527 Published:June 2018 20180601 Last updated:June 2018 20180627
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease Reference number:TA217 TA00217 Published:March 2011 20110301 Last updated:June 2018 20180620
Guselkumab for treating moderate to severe plaque psoriasis Reference number:TA521 TA00521 Published:June 2018 20180601 Last updated:June 2018 20180613
Pembrolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable Reference number:TA522 TA00522 Published:June 2018 20180601 Last updated:June 2018 20180613